自己資本利益率 (ROE)
2018年以降
計算
Moderna Inc.、 ROE、長期トレンド計算
| ROE | = | 100 | × | 当期純利益(損失)1 | ÷ | 株主資本1 | |
|---|---|---|---|---|---|---|---|
| 2023/12/31 | -34.03% | = | 100 | × | (4,714) | ÷ | 13,854) |
| 2022/12/31 | 43.73% | = | 100 | × | 8,362) | ÷ | 19,123) |
| 2021/12/31 | 86.26% | = | 100 | × | 12,202) | ÷ | 14,145) |
| 2020/12/31 | -29.17% | = | 100 | × | (747) | ÷ | 2,561) |
| 2019/12/31 | -43.75% | = | 100 | × | (514) | ÷ | 1,175) |
| 2018/12/31 | -25.14% | = | 100 | × | (385) | ÷ | 1,530) |
レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31).
1 百万米ドル
競合他社との比較
Moderna Inc.、 ROE、長期トレンド、競合他社との比較
| Moderna Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023/12/31 | -34.03% | 46.94% | 107.78% | 27.27% | 8.91% | 48.65% | 24.81% | 51.11% | 0.97% | 2.38% | 15.22% | 12.83% |
| 2022/12/31 | 43.73% | 68.60% | 178.97% | 20.37% | 14.39% | 58.64% | 21.62% | 23.36% | 31.57% | 32.79% | 19.14% | 15.80% |
| 2021/12/31 | 86.26% | 74.91% | 87.96% | 19.46% | 14.24% | 62.16% | 29.55% | 28.20% | 34.17% | 28.47% | 43.03% | 18.94% |
| 2020/12/31 | -29.17% | 35.30% | 77.20% | -23.84% | 9.17% | 109.79% | 0.68% | 23.25% | 27.91% | 15.21% | 31.86% | 18.47% |
| 2019/12/31 | -43.75% | — | 81.07% | 6.66% | 9.94% | 319.09% | 23.91% | 25.42% | 37.99% | 25.77% | 19.08% | 12.45% |
| 2018/12/31 | -25.14% | — | 67.15% | 35.07% | 9.40% | 32.88% | 25.51% | 25.60% | 23.30% | 17.59% | 27.91% | 10.65% |
レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31).
産業部門との比較: 製薬、バイオテクノロジー、ライフサイエンス
Moderna Inc.、 ROE、長期トレンド、産業部門との比較: 製薬、バイオテクノロジー、ライフサイエンス
| Moderna Inc. | 製薬、バイオテクノロジー、ライフサイエンス | |
|---|---|---|
| 2023/12/31 | -34.03% | 18.83% |
| 2022/12/31 | 43.73% | 28.81% |
| 2021/12/31 | 86.26% | 31.93% |
| 2020/12/31 | -29.17% | 16.48% |
| 2019/12/31 | -43.75% | 27.56% |
| 2018/12/31 | -25.14% | 25.64% |
レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31).
業界との比較: 医療
Moderna Inc.、 ROE、長期トレンド、業界との比較: 医療
| Moderna Inc. | 医療 | |
|---|---|---|
| 2023/12/31 | -34.03% | 17.03% |
| 2022/12/31 | 43.73% | 22.88% |
| 2021/12/31 | 86.26% | 24.08% |
| 2020/12/31 | -29.17% | 15.82% |
| 2019/12/31 | -43.75% | 20.90% |
| 2018/12/31 | -25.14% | 17.33% |
レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31).